Shandong Pharmaceutical Glass Co Ltd
SSE:600529
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
21.75
31.97
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Shandong Pharmaceutical Glass Co Ltd
Accounts Receivables
Shandong Pharmaceutical Glass Co Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Accounts Receivables
¥971.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
8%
|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Accounts Receivables
¥6.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Accounts Receivables
¥1.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Accounts Receivables
¥768.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Accounts Receivables
¥620.5m
|
CAGR 3-Years
42%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Accounts Receivables
¥1.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Shandong Pharmaceutical Glass Co Ltd
Glance View
In the vast landscape of China's industrial might lies Shandong Pharmaceutical Glass Co Ltd., a company serving as a key player in the healthcare and pharmaceutical sectors. Established in 1970, the company has developed a reputation as a leading manufacturer and supplier of pharmaceutical packaging, particularly glass containers. It specializes in producing molded glass and glass tubing that form the backbone of safe and reliable drug delivery systems, including ampoules, vials, and cartridges. Over the decades, Shandong Pharmaceutical Glass Co Ltd. has leveraged its expertise in glass manufacturing to meet stringent industry standards and cater to the ever-evolving needs of its clients, ranging from pharmaceutical giants to smaller biotech firms. At the heart of its business model, Shandong Pharmaceutical Glass generates revenue by providing essential packaging solutions that are integral to the pharmaceutical supply chain. The company's success hinges on its ability to innovate and produce high-quality, durable glass products that ensure the integrity and safety of medicinal products during storage, transportation, and administration. With the rising global demand for pharmaceuticals, particularly in Asia Pacific markets, Shandong Pharmaceutical Glass's focus on sustainable, efficient, and technologically advanced manufacturing processes positions it strategically to capitalize on growth opportunities. By embedding itself in the pharmaceutical lifecycle, the company not only safeguards medications but also fortifies its own standing in a rapidly expanding industry.
See Also
What is Shandong Pharmaceutical Glass Co Ltd's Accounts Receivables?
Accounts Receivables
971.3m
CNY
Based on the financial report for Sep 30, 2024, Shandong Pharmaceutical Glass Co Ltd's Accounts Receivables amounts to 971.3m CNY.
What is Shandong Pharmaceutical Glass Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
8%
Over the last year, the Accounts Receivables growth was -1%. The average annual Accounts Receivables growth rates for Shandong Pharmaceutical Glass Co Ltd have been 9% over the past three years , 19% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
